Cencora
Sign in to saveAlso known as AmerisourceBergen Corporation, AmerisourceBergen World Courier, Cencora, Inc.
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.
OverviewAI-generated
Cencora, also known as AmerisourceBergen, is an operating company established in 2001. It is located in Chesterbrook, United States, and was incorporated in Delaware. The organization is classified under the wholesale drugs, proprietaries, and druggists' sundries industry.
The company is listed on the New York Stock Exchange under the ticker symbol COR. It is recognized in the S&P 500 collection. Cencora employs 44,000 people and concludes its fiscal year on September 30.
Synthesized by Vinony from 24 facts across 5 sources: Wikidata, Firecrawl, SEC EDGAR, ROR, Vinony collections. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
In the Vinony graph
Cencora is indexed among the 527 entries in Vinony's S&P 500 Companies collection.
Within Vinony's link graph, Cencora is referenced by 680 other articles, and connects out to medication, United States Department of Health and Human Services and United States.
It sits within the topics American companies established in 2001, Companies based in Chester County, Pennsylvania and Companies based in Philadelphia.
Its subject is documented across 17 Wikipedia language editions.
Key facts
- Company.name
- Cencora, Inc.
- Company.logo
- Cencora logo.png
- Company.former_name
- AmerisourceBergen Corporation (2001–2023)
- Company.type
- Public
- Company.founded
- (merger between AmeriSource Health and Bergen Brunswig)
- Company.operating_income
- (2025)
- Company.net_income
- (2025)
- Company.owner
- Walgreens Boots Alliance (10%)
- Company.num_employees
- (2025)
- Company.products
- Pharmaceuticals and pharmacy services
- Company.industry
- Pharmaceutical industry
- Company.image
- Cencora-headquarters-by-bill-cramer.jpg
- Company.image_caption
- Cencora Headquarters Conshohocken, PA
- Company.footnotes
- Financials .
via Wikipedia infobox
Company
COR- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Exchange
- NYSE
- State of incorporation
- DE
- Entity type
- operating
- Fiscal year end
- Sep 30
- Latest filing
- 8-K · 2026-05-29
- Jurisdiction
- US-DE
- Headquarters
- Conshohocken, US
Research organization · ROR
- Type
- Company
- Founded
- 2001
- Location
- Chesterbrook, United States
- Status
- Active
GRID grid.482925.0 · ISNI 0000 0004 0408 1610
Wikidata facts
- Instance of
- public company
- Part of
- S&P 500
- Country
- United States
- Headquarters
- Chesterbrook
- Owned by
- BlackRock
- Industry
- pharmaceutical industry
- Employees
- 44000
- Revenue
- 238587006000
- Stock exchange
- New York Stock Exchange
- Legal form
- Delaware corporation
- Official website
- www.cencora.com
Show 6 more facts
- inception
- 2001-01-01
- product or material produced
- medication
- social media followers
- 4771
- net profit
- 1698820000
- operating income
- 2366378000
- Commons category
- Cencora
Sources (13)
via Wikidata · CC0
~8 min read
Encyclopedic overview
11 sectionsContents
- Background
- Products
- Good Neighbor Pharmacy
- Acquisition history
- Distribution of Remdesivir
- Finances
- Controversies
- Opioid epidemic
- Legal issues
- References
- External links
[menu toggle](http://www.amerisourcebergen.com/#)
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.
Excerpted from Wikipedia’s “Cencora” article, available under the CC BY-SA 4.0 licence.